Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Cytokinetic effects of adriamycin (ADR) in a human lymphoma cell line
B. Barlogie
, B. Drewinko
, J. S. Hart
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cytokinetic effects of adriamycin (ADR) in a human lymphoma cell line'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Lymphoma Cell
100%
Adriamycin
100%
Lymphoma Cells
100%
Cytokinetics
100%
Exposure Time
33%
Short-term Exposure
33%
Incubation
16%
Cell Cycle Progression
16%
Lethal Effects
16%
Cell Killing
16%
Histogram
16%
4-fold
16%
Concentration-dependent
16%
G1-S Transition
16%
G2 Phase
16%
Blocking Effect
16%
Predictive Test
16%
G2 Arrest
16%
Cytophotometry
16%
Partially Reversible
16%
Immunology and Microbiology
Cell Cycle
100%
Cell Kinetics
100%
Lymphoma Cell Line
100%
Cell Line
50%
Cell Killing
50%
Pulse Rate
50%
Cell Cycle Progression
50%
Cell Cycle G2 Phase
50%
G2 Phase Cell Cycle Checkpoint
50%
Medicine and Dentistry
Doxorubicin
100%
Cell Kinetics
100%
Lymphoma Cell Line
100%
Cell Cycle
33%
G1/S Transition
16%
Cell Cycle Progression
16%
Cell Line
16%
Pulse Rate
16%
Incubation
16%
G2 Phase Cell Cycle Checkpoint
16%
Cytophotometry
16%
Cell Killing
16%
G2 Phase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Veterinary Science and Veterinary Medicine
Doxorubicin
100%
Social Sciences
Histogram
100%